Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

Mayo Clinic Proceedings

Volumn 75, Issue 4, 2000, Pages 355-359

  Knobler, Hilla ^a   Schihmanter, Renata ^a   Zifroni, Abraham ^a   Fenakel, Gabriel ^b   Schattner, Ami ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; RISK FACTOR; VIRUS HEPATITIS;

EID: 0034032877     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.4.355     Document Type: Article

References (25)

1. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease: review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-620.
2. Di Bisceglie AM. Hepatitis C. Lancet. 1998;351:351-355.
3. Gray H, Wreghitt T, Stratton IM, Alexander GJ, Turner RC, O'Rahilly S. High prevalence of hepatitis C infection in AfroCaribbean patients with type 2 diabetes and abnormal liver function tests. DiabetMed. 1995; 12:244-249.
4. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care. 1996;19:998-1000.
5. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994;21:1135-1139.
6. Fraser GM, Harman I, Meiler N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. IsrJMedSci. 1996;32:526-530.
7. Grimbert S, Valensi P, Levy-Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C: a case-control study. GastroenterolClinBiol. 1996;20:544-548.
8. Ozyilkan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection [letter]. Am J Gastroenterol. 1996;91:1480-1481.
9. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998:26:30-33.
10. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999; 29:328-333.
11. Kruszynska YT. Mclntyre N. Carbohydrate metabolism. In: Mclntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford, England: Oxford University Press; 1991:129-143.
12. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition. 1999; 15:583-589.
13. Mangia A, Schiavone G, Lezzi G, et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol. 1998:93: 2363-2367.
14. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1:431-435.
15. Zifroni A. The role of the physician in the donor process. In: Fabry TL, Klion FM, eds. Guide to Liver Transplantation. New York, NY: Igaku-Shoin; 1992:47-54.
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
17. Stern E, Blau J, Rusecki Y, Rafaelovsky M, Cohen MP. Prevalence of diabetes in Israel: epidemiologic survey. Diabetes. 1988:37:297-302.
18. Chedin P, Cahen-Varsaux J, Boyer N. Non-insulin-dependenl diabetes mellitus developing during interferon-alpha therapy tor chronic hepatitis C [letter]. Ann Intern Med. 1996; 125:521.
19. Okanoue T, Sakamoto S, Itoh Y. et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996:25:283-291.
20. Ito Y. Takeda N, Ishimori M, Akai A, Miura K, Yasuda K. Effect of long-term interferon-a treatment on glucose tolerance in patients with chronic hepatitis C. J Hepatol. 1999:31:215-220.
21. Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltorti M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract. 1990;8:29-36.
22. Hadziyannis S, Karamanos B. Diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:604-605.
23. Petrides AS. DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev. 1989:5:691-709.
24. Itoh Y. Okanoue T, Ohnishi N. et al. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1999:94:1332-1340.
25. Kanety H. Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1): possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. ./ Biol Client. 1995:270:23780-23784.